Revenue and Sales Performance - AXT's substrate product group generated 63% of consolidated revenue in 2023, while the raw materials product group accounted for 37%[157]. - AXT's consolidated revenue percentages for substrate and raw materials were 79% and 21% in 2022, and 75% and 25% in 2021, respectively[157]. - Revenue increased by 6.3million,or36.223.6 million for the three months ended September 30, 2024, compared to 17.4millionforthesameperiodin2023[212].−Revenueincreasedby18.9 million, or 34.1%, to 74.3millionfortheninemonthsendedSeptember30,2024,comparedto55.4 million for the same period in 2023[213]. - Substrate revenue for the nine months ended September 30, 2024, increased by 16.8million,or48.051.7 million from 34.9millioninthesameperiodin2023[214].−RevenueinChinaincreasedby13.6 million, or 47.3%, for the nine months ended September 30, 2024, primarily due to higher demand for GaAs, InP, and Ge wafer substrates[218]. - Revenue in Taiwan increased by 3.8million,or59.21.8 million, or 260.8%, for the three months ended September 30, 2024, primarily due to higher demand for InP wafer substrates[217]. - Revenue in Europe increased by 2.1million,or23.810.7 million, or 123.5%, to 19.4millionfrom8.7 million for the same period in 2023[222]. - Gross margin as a percentage of revenue increased to 26.2% for the nine months ended September 30, 2024, compared to 15.7% for the same period in 2023[222]. - Selling, general and administrative expenses increased by 217,000,or1.217.7 million for the nine months ended September 30, 2024, compared to 17.4millionforthesameperiodin2023[225].−Researchanddevelopmentexpensesincreasedby1.1 million, or 12.4%, to 10.4millionfortheninemonthsendedSeptember30,2024,primarilyduetohigherdevelopmentexpensesforcrystalingotprocessing[227].CashFlowandLiquidity−Cashandshort−terminvestmentsdecreasedby11.3 million in the nine months ended September 30, 2024, primarily due to net cash used in operating activities of 13.4million[237].−AsofSeptember30,2024,theprincipalsourceofliquiditywas38.8 million, consisting of cash of 24.9millionandrestrictedcashof13.9 million[237]. - Net cash used in operating activities was 13.4millionfortheninemonthsendedSeptember30,2024,primarilyduetoanetlossbeforeincomeattributabletononcontrollinginterestsof6.1 million[239]. - The company has adequate cash and investments to meet operating needs and capital expenditures over the next 12 months[259]. Investments and Financing - The company has a total investment target of approximately 90millioninvalue,assets,andcapitalforitsnewmanufacturingfacilityinDingxing,China[262].−Thecompanyexpectstousenetproceedsfroma60 million Shelf Registration Statement for working capital, capital expenditures, and potential acquisitions[258]. - The company secured a new line of credit amounting to 9.7million,structuredasafive−yearbankloanwithaninterestrateof6.50.2 million in 2023, down from 1.6millionin2022,andanetforeignexchangelossof0.4 million in 2021[266]. Regulatory and Geopolitical Risks - The company anticipates potential challenges related to geopolitical tensions and regulatory changes affecting its operations in China[150]. - Effective August 1, 2023, the PRC government requires export licenses for gallium and germanium-related materials, impacting shipment timelines[176]. - The company is subject to unique legal and operational risks associated with its corporate structure, which could materially affect operations and stock value[179]. Corporate Structure and Governance - AXT's PRC subsidiary, Tongmei, received a total investment of approximately 49millionfromprivateequityfirms,grantingthema7.2849 million as part of the IPO process[252]. - Tongmei's IPO application was accepted for review by the Shanghai Stock Exchange on January 10, 2022, and approved on July 12, 2022[253].